CCNO Gene Primary Ciliary Dyskinesia Type 29 Genetic Test
At DNA Labs UAE, we offer the CCNO Gene Primary Ciliary Dyskinesia Type 29 Genetic Test. This test is designed to identify mutations in the CCNO gene, which is associated with a rare genetic disorder called primary ciliary dyskinesia type 29.
Primary ciliary dyskinesia (PCD) is a heterogeneous group of genetic disorders characterized by impaired function of cilia in various organs. This can lead to respiratory, sinus, and fertility problems. By analyzing multiple genes simultaneously using NGS (Next-Generation Sequencing) technology, we can identify mutations in the CCNO gene and confirm a diagnosis of primary ciliary dyskinesia.
Test Details
Test Name: CCNO Gene Primary Ciliary Dyskinesia Type 29 Genetic Test
Components: NGS Technology
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Test Type: Ear Nose Throat Disorders
Doctor: ENT Doctor
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test gene SLC52A19
Why Choose NGS Testing for Primary Ciliary Dyskinesia?
NGS testing is a powerful tool that allows us to analyze multiple genes simultaneously. In the case of primary ciliary dyskinesia, NGS can be used to identify mutations in the CCNO gene, among others, to confirm a diagnosis. This type of genetic testing can provide valuable information for treatment and management options.
If you suspect primary ciliary dyskinesia or have a family history of the condition, it is recommended to consult with a genetic counselor or a healthcare professional experienced in genetic testing. They can help determine if NGS testing, including CCNO gene analysis, is appropriate for you or your family member.
At DNA Labs UAE, we are dedicated to providing accurate and reliable genetic testing services. Our team of experts is here to support you throughout the testing process and provide you with the information you need for better treatment and management of primary ciliary dyskinesia.
| Test Name | CCNO Gene Primary ciliary dyskinesia type 29 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Ear Nose Throat Disorders |
| Doctor | ENT Doctor |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test gene SLC52A19 |
| Test Details | CCNO gene, also known as cyclin O, is associated with a rare genetic disorder called primary ciliary dyskinesia type 29. Primary ciliary dyskinesia (PCD) is a heterogeneous group of genetic disorders characterized by impaired function of cilia in various organs, leading to respiratory, sinus, and fertility problems. NGS (Next-Generation Sequencing) genetic testing is a powerful tool used to analyze multiple genes simultaneously. In the case of primary ciliary dyskinesia, NGS can be used to identify mutations in the CCNO gene, among others, to confirm a diagnosis. This type of genetic testing can help identify the specific genetic variant causing the disorder and provide valuable information for treatment and management options. If you suspect primary ciliary dyskinesia or have a family history of the condition, consulting with a genetic counselor or a healthcare professional experienced in genetic testing can help determine if NGS testing, including CCNO gene analysis, is appropriate for you or your family member. |
